Cancer Prevention


Spring 2006
Issue 7


Past Issue Archive
Calendar of Events
May

May 4-7
Oncology Nursing Society 31st Annual Congress
Boston, MA
View site

May 17-19
AACR Accelerating Anticancer Agent Development and Validation Workshop
North Bethesda, MD
View site

May 19
PAC3 Second Annual Summit: Access in Action: Navigating the Cancer Continuum
Harrisburg, PA
View site

May 19-24
American Thoracic Society
San Diego, CA
View site

May-November

 
Cancer Prevention | Issue Seven


[In Feature]
Aging and CancerAging and Cancer
A Timeless Concern for Prevention Effort
Although cancer occurs at all ages, the highest incidence and mortality rates occur in those over 65 years of age. Research continues to assess the best prevention and early detection efforts in this age group. [more]
 
Nicotine Vaccine: A Promising Treatment for Nicotine AddictionNicotine Vaccine: A Promising Treatment for Nicotine Addiction
Lung cancer remains the leading cause of cancer-related death in the US, a total greater than for the other five leading cancers combined. Most lung cancer cases are smoking related, and while the numbers of smokers in the US are declining, approximately 45 million Americans continue to smoke. [more]
 
Molecular Clues to Preventing Tobacco-Related Lung Cancer
Almost every article on lung cancer opens with the grim statistics: over 172,000 new cases of cancer expected each year in the US, over 163,000 expected deaths; 1.35 million new cases and 1.18 million deaths each year worldwide; the leading cause of cancer deaths for both men and women; an overall 5-year relative survival rate of 15%. [more]
 
Spotlight On….
Scott M. Lippman, MD, has devoted a large part of his time over the last 25 years to trying to prevent cancer. His worldwide recognition for this work includes receiving the 2005 American Association for Cancer Research (AACR)-Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research. [more]
 
Promoting a State of Prevention
The Pennsylvania Cancer Control Consortium (PAC3) is an initiative formed in 2001 to reduce the human and economic burden of cancer by creating the first-ever Pennsylvania Comprehensive Cancer Control Plan. [more]
 
Smoke-Free Workplace States
Washington is the ninth state to adopt a comprehensive, statewide smoke-free workplace law that includes restaurants and bars. [more]
 
Cervical Cancer Vaccine May Be on the Horizon
Human papillomavirus (HPV) has been identified as the cause of cervical cancer, pre-cancers, benign cervical lesions, and genital warts. [more]
2005 Nobel Prize in Physiology or Medicine Recognizes Research on H. Pylori
Australian researchers J. Robin Warren and Barry Marshall were awarded the recent Nobel Prize in Physiology or Medicine for their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease. This discovery has led to an increased understanding of the connection between chronic infection, inflammation, and cancer. The severity of the inflammation that results from H. pylori infection in the stomach is of crucial importance for the diseases that can result. In some people, H. pylori infects the corpus region of the stomach, resulting in a widespread inflammation that predisposes the person not only to peptic ulcer disease, but also to stomach cancer. Although the incidence of this particular malignancy has decreased in many developed countries during the past 50 years, it still ranks among the most common malignancies worldwide, with over 850,000 cases and 650,000 deaths each year.
[In Letter From the Editors]
Letter From the EditorsLetter From the Editors
The field of cancer prevention focuses on trying to find risk factors for cancer that can be avoided or modified. The one omnipresent and inevitable risk factor to which all of us are subject is age. [more]
[In News from the NCI]
News from the NCI
Centers of Cancer Nanotechnology Excellence Think Small to Make Big Changes in Cancer Prevention, Diagnosis and Treatment
The NCI recently awarded funding to establish eight Centers of Cancer Nanotechnology Excellence (CCNEs). Through these programs, researchers will harness the power of nanotechnology and apply it to the major challenges of basic research and clinical oncology to improve early detection, diagnosis and treatment of cancer. [more]
[In Issues & Insights]
Issues & Insights
Many aspects of our current paradigm regarding cancer prevention originated at a time when most cancers were regarded as more or less homogenous collections of transformed cells. Today, it is worth reconsidering many of our commonly used preventive approaches in view of recent insights into the heterogeneous nature of many solid tumors, and the key role played by cancer stem cells. [more]
[In Cinical]
Cancer Prevention Clinical Trials
If you are interested in learning more about a trial, access the Web site address or call the phone number provided for additional information. [more]
Cancer Prevention Legislation
[In Legislation]
State Legislation
Legislation pertaining to cancer and its prevention that is under consideration in various states. [more]
 
Federal Legislation
Federal legislation pertaining to cancer and its prevention that is under consideration in the US Congress. [more]
[In Additional Information]
Make Your Voice HeardMake Your Voice Heard
Contact your Congressional representatives, the White House, or other government agencies to express your support of cancer prevention legislation and to urge the funding of cancer prevention research. [more]
 
Other Information Resources
[more]
Cancer Prevention Mailing List
Sign up for the Cancer Prevention Online Newsletter mailing list.
First Name:  
Last Name:
E-mail:
E-mail Confirmation:
Zip/Postal Code:
 
Back to Top
 
NewYork-Presbyterian. The University Hospitals of Columbia and Cornell